Powder: -20°C for 3 years | In solvent: -80°C for 1 year
C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle. C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 1,187.00 | |
5 mg | Inquiry | $ 2,569.00 |
Description | C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle. C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder. |
Molecular Weight | 862.18 |
Formula | C46H87NO13 |
CAS No. | 4201-62-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform:Methanol:H2O (2:1:0.1): Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
C16 Lactosylceramide (d18:1/16:0) 4201-62-1 C16 Lactosylceramide C-16 Lactosylceramide (d18:1/16:0) d18:1/16:0 inhibitor inhibit